Acute myeloid leukaemia (in remission) Recruiting Phase 1 / 2 Trials for Mechlorethamine (DB00888)

Also known as: Acute Myeloid Leukemia in Remission / Acute myeloid leukemia (in remission) / Acute myeloblastic leukemia, in remission / Acute myeloid leukaemia in remission

IndicationStatusPhase
DBCOND0006975 (Acute myeloid leukaemia (in remission))Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01904136Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaTreatment